« Back to Record
Citation APA

Maertens, J., Aoun, M., Baddley, J. J., Giladi, M., Heinz, W. W., Herbrecht, R., Hope, W., Karthaus, M., Lee, D. G., Lortholary, O., Morrison, V. A., Raad, I. I., Oren, I., Selleslag, D., Shoham, S., Thompson, G. R., Lee, M., Maher, R. R., Schmitt-Hoffmann, A. H., Zeiher, B., Ullmann, A., Marr, K. K., Patterson, T. F., Kontoyiannis, D. D., Cornely, O. A., Bow, E. J., Rahav, G., & Neofytos, D. (2016). Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): A phase 3, randomised-controlled, non-inferiority trial. Lancet, 387(10020), 760-769. doi:10.1016/S0140-6736(15)01159-9


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/231579

Maertens, J., Aoun, M., Baddley, J. J., Giladi, M., Heinz, W. W., Herbrecht, R., Hope, W., Karthaus, M., Lee, D. G., Lortholary, O., Morrison, V. A., Raad, I. I., Oren, I., Selleslag, D., Shoham, S., Thompson, G. R., Lee, M., Maher, R. R., Schmitt-Hoffmann, A. H., Zeiher, B., Ullmann, A., Marr, K. K., Patterson, T. F., Kontoyiannis, D. D., Cornely, O. A., Bow, E. J., Rahav, G., & Neofytos, D. (2016). Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): A phase 3, randomised-controlled, non-inferiority trial. Lancet, 387(10020), 760-769. doi:10.1016/S0140-6736(15)01159-9